» Articles » PMID: 36257906

SRSF5-Mediated Alternative Splicing of M Gene is Essential for Influenza A Virus Replication: A Host-Directed Target Against Influenza Virus

Overview
Journal Adv Sci (Weinh)
Date 2022 Oct 18
PMID 36257906
Authors
Affiliations
Soon will be listed here.
Abstract

Splicing of influenza A virus (IAV) RNA is an essential process in the viral life cycle that involves the co-opting of host factors. Here, it is demonstrated that induction of host serine and arginine-rich splicing factor 5 (SRSF5) by IAV facilitated viral replication by enhancing viral M mRNA splicing. Mechanistically, SRSF5 with its RRM2 domain directly bounds M mRNA at conserved sites (M mRNA position 163, 709, and 712), and interacts with U1 small nuclear ribonucleoprotein (snRNP) to promote M mRNA splicing and M2 production. Mutations introduced to the three binding sites, without changing amino acid code, significantly attenuates virus replication and pathogenesis in vivo. Likewise, SRSF5 conditional knockout in the lung protects mice against lethal IAV challenge. Furthermore, anidulafungin, an approved antifungal drug, is identified as an inhibitor of SRSF5 that effectively blocks IAV replication in vitro and in vivo. In conclusion, SRSF5 as an activator of M mRNA splicing promotes IAV replication and is a host-derived antiviral target.

Citing Articles

Profiling Cullin4-E3 Ligases Interactomes and Their Rewiring in Influenza A Virus Infection.

Dugied G, Douche T, Dos Santos M, Giai Gianetto Q Q, Cassonnet C, Vuillier F Mol Cell Proteomics. 2024; 23(11):100856.

PMID: 39383947 PMC: 11609542. DOI: 10.1016/j.mcpro.2024.100856.


The U1-70K and SRSF1 interaction is modulated by phosphorylation during the early stages of spliceosome assembly.

Paul T, Zhang P, Zhang Z, Fargason T, De Silva N, Powell E Protein Sci. 2024; 33(8):e5117.

PMID: 39023093 PMC: 11255866. DOI: 10.1002/pro.5117.


SARS-CoV-2 Nsp1 cooperates with initiation factors EIF1 and 1A to selectively enhance translation of viral RNA.

Aviner R, Lidsky P, Xiao Y, Tassetto M, Kim D, Zhang L PLoS Pathog. 2024; 20(2):e1011535.

PMID: 38335237 PMC: 10903962. DOI: 10.1371/journal.ppat.1011535.


Virus usurps alternative splicing to clear the decks for infection.

Li R, Gao S, Chen H, Zhang X, Yang X, Zhao J Virol J. 2023; 20(1):131.

PMID: 37340420 PMC: 10283341. DOI: 10.1186/s12985-023-02098-9.


Serine-arginine protein kinases and their targets in viral infection and their inhibition.

Zheng K, Ren Z, Wang Y Cell Mol Life Sci. 2023; 80(6):153.

PMID: 37198350 PMC: 10191411. DOI: 10.1007/s00018-023-04808-6.


References
1.
Subramania S, M Gagne L, Campagne S, Fort V, OSullivan J, Mocaer K . SAM68 interaction with U1A modulates U1 snRNP recruitment and regulates mTor pre-mRNA splicing. Nucleic Acids Res. 2019; 47(8):4181-4197. PMC: 6486544. DOI: 10.1093/nar/gkz099. View

2.
Dubois J, Terrier O, Rosa-Calatrava M . Influenza viruses and mRNA splicing: doing more with less. mBio. 2014; 5(3):e00070-14. PMC: 4030477. DOI: 10.1128/mBio.00070-14. View

3.
Huang L, Welsh D, Miller R, Ben Beard C, Lawrence G, Fox M . Pneumocystis jirovecii dihydropteroate synthase gene mutations and human immunodeficiency virus-associated Pneumocystis pneumonia. J Eukaryot Microbiol. 2006; 53 Suppl 1:S114-6. DOI: 10.1111/j.1550-7408.2006.00195.x. View

4.
Lu L, Su S, Yang H, Jiang S . Antivirals with common targets against highly pathogenic viruses. Cell. 2021; 184(6):1604-1620. DOI: 10.1016/j.cell.2021.02.013. View

5.
Twyffels L, Gueydan C, Kruys V . Shuttling SR proteins: more than splicing factors. FEBS J. 2011; 278(18):3246-55. DOI: 10.1111/j.1742-4658.2011.08274.x. View